HIV Citation List: February 17 - March 1, 2012

Pubmed citations

1. Synthesis and anti-HIV Activities of Glutamate and Peptide Conjugates of Nucleoside Reverse Transcriptase Inhibitors. Agarwal, H.K., B.S. Chhikara, M. Quiterio, G.F. Doncel, and K. Parang, Journal of Medicinal Chemistry, 2012. [Epub ahead of print]; PMID[22352809].
[PubMed]. HIV_0217-030112.

2. Emerging Drugs for the Treatment of Human Immunodeficiency Virus. Bhopale, G.M., Recent Patents on Antiinfective Drug Discovery, 2012. [Epub ahead of print]; PMID[22353003].
[PubMed]. HIV_0217-030112.

3. Daphnane-type Diterpene Esters with Cytotoxic and anti-HIV-1 Activities from Daphne acutiloba Rehd. Huang, S.Z., X.J. Zhang, X.Y. Li, L.M. Kong, H.Z. Jiang, Q.Y. Ma, Y.Q. Liu, J.M. Hu, Y.T. Zheng, Y. Li, J. Zhou, and Y.X. Zhao, Phytochemistry, 2012. 75: p. 99-107; PMID[22196934].
[PubMed]. HIV_0217-030112.

4. A Quantitative Basis for Antiretroviral Therapy for HIV-1 Infection. Jilek, B.L., M. Zarr, M.E. Sampah, S.A. Rabi, C.K. Bullen, J. Lai, L. Shen, and R.F. Siliciano, Nature Medicine, 2012. [Epub ahead of print]; PMID[22344296].
[PubMed]. HIV_0217-030112.

5. Inhibitors of Human Immunodeficiency Virus Type 1 (HIV-1) Attachment 6. Preclinical and Human Pharmacokinetic Profiling of BMS-663749, a Phosphonooxymethyl Prodrug of the HIV-1 Attachment Inhibitor 2-(4-Benzoyl-1-piperazinyl)-1-(4,7-dimethoxy-1H-pyrrolo[2,3-c]pyridin-3-yl)-2-oxo ethanone (BMS-488043). Kadow, J.F., Y. Ueda, N.A. Meanwell, T.P. Connolly, T. Wang, C.P. Chen, K.S. Yeung, J. Zhu, J.A. Bender, Z. Yang, D. Parker, P.F. Lin, R.J. Colonno, M. Mathew, D. Morgan, M. Zheng, C. Chien, and D. Grasela, Journal of Medicinal Chemistry, 2012. [Epub ahead of print]; PMID[22356441].

[PubMed]. HIV_0217-030112.

6. Discovery of 3,4-Dihydropyrimidin-2(1H)-ones with Inhibitory Activity against HIV-1 Replication. Kim, J., C. Park, T. Ok, W. So, M. Jo, M. Seo, Y. Kim, J.H. Sohn, Y. Park, M.K. Ju, S.J. Han, T.H. Kim, J. Cechetto, J. Nam, P. Sommer, and Z. No, Bioorganic & Medicinal Chemistry Letters, 2012. 22(5): p. 2119-2124; PMID[22305583].
[PubMed]. HIV_0217-030112.

7. Complex Drug Interactions of the HIV Protease Inhibitors 3: Effect of Simultaneous or Staggered Dosing of Digoxin and Ritonavir, Nelfinavir, Rifampin, or Bupropion. Kirby, B.J., A.C. Collier, E.D. Kharasch, D. Whittington, K.E. Thummel, and J.D. Unadkat, Drug Metabolism and Disposition, 2012. 40(3): p. 610-616; PMID[22190694].
[PubMed]. HIV_0217-030112.

8. Synthesis, 2D-NMR and Molecular Modelling Studies of Pentacycloundecane lactam-peptides and Peptoids as Potential HIV-1 Wild Type C-SA Protease Inhibitors. Makatini, M.M., K. Petzold, C.N. Alves, P.I. Arvidsson, B. Honarparvar, P. Govender, T. Govender, H.G. Kruger, Y. Sayed, Jeronimolameira, G.E. Maguire, and M.E. Soliman, Journal of Enzyme Inhibition and Medicinal Chemistry, 2012. [Epub ahead of print]; PMID[22339087].
[PubMed]. HIV_0217-030112.

9. Suppression of Pre Adipocyte Differentiation and Promotion of Adipocyte Death by anti-HIV Drugs. Manente, L., A. Lucariello, C. Costanzo, R. Viglietti, G. Parrella, R. Parrella, M. Gargiulo, D.E.L. A, A. Chirianni, and V. Esposito, In Vivo, 2012. 26(2): p. 287-291; PMID[22351671].
[PubMed]. HIV_0217-030112.

10. Antiviral Activity of Recombinant Ankyrin Targeted to the Capsid Domain of HIV-1 Gag Polyprotein. Nangola, S., A. Urvoas, M. Valerio-Lepiniec, W. Khamaikawin, S. Sakkhachornphop, S.S. Hong, P. Boulanger, P. Minard, and C. Tayapiwatana, Retrovirology, 2012. 9(1): p. 17; PMID[22348230].

[PubMed]. HIV_0217-030112.

11. Discovery of the First Small Molecule Inhibitor of Human DDX3 Specifically Designed to Target the RNA Binding Site: Towards the Next Generation HIV-1 Inhibitors. Radi, M., F. Falchi, A. Garbelli, A. Samuele, V. Bernardo, S. Paolucci, F. Baldanti, S. Schenone, F. Manetti, G. Maga, and M. Botta, Bioorganic & Medicinal Chemistry Letters, 2012. 22(5): p. 2094-2098; PMID[22300661].
[PubMed]. HIV_0217-030112.

12. Comparative Study of Biological Activity of Three Commercial Products of Sasa senanensis Rehder Leaf Extract. Sakagami, H., S. Iwamoto, T. Matsuta, K. Satoh, C. Shimada, T. Kanamoto, S. Terakubo, H. Nakashima, Y. Morita, A. Ohkubo, T. Tsuda, K. Sunaga, M. Kitajima, H. Oizumi, and T. Oizumi, In Vivo, 2012. 26(2): p. 259-264; PMID[22351667].
[PubMed]. HIV_0217-030112.

13. Critical Differences in HIV-1 and HIV-2 Protease Specificity for Clinical Inhibitors. Tie, Y., Y.F. Wang, P.I. Boross, T.Y. Chiu, A.K. Ghosh, J. Tozser, J.M. Louis, R.W. Harrison, and I.T. Weber, Protein Science, 2012. 21(3): p. 339-350; PMID[22238126].
[PubMed]. HIV_0217-030112.

14. Phosphoramidate Prodrugs of (-)-beta-D-(2R,4R)-Dioxolane-thymine (DOT) as Potent anti-HIV Agents. Wang, P., S. Rachakonda, V. Zennou, M. Keilman, C. Niu, D. Bao, B.S. Ross, P.A. Furman, M.J. Otto, and M.J. Sofia, Antiviral Chemistry & Chemotherapy, 2012. [Epub ahead of print]; PMID[22358223].

[PubMed]. HIV_0217-030112.

15. Synthesis and Biological Evaluation of Novel Amprenavir-based P1-substituted Bi-aryl Derivatives as Ultra-potent HIV-1 Protease Inhibitors. Yan, J., N. Huang, S. Li, L.M. Yang, W. Xing, Y.T. Zheng, and Y. Hu, Bioorganic & Medicinal Chemistry Letters, 2012. 22(5): p. 1976-1979; PMID[22306123].
[PubMed]. HIV_0217-030112.

ISI Web of Knowledge citations

16. Dolutegravir-A Promising Antiretroviral in Development. Boyd, M., Lancet Infectious Diseases, 2012. 12(2): p. 90-91; ISI[000299656000026].
[WOS]. HIV_0217-030112.

17. Plant Defensins and Defensin-Like Peptides - Biological Activities and Biotechnological Applications. Carvalho, A.D. and V.M. Gomes, Current Pharmaceutical Design, 2011. 17(38): p. 4270-4293; ISI[000299643100005].
[WOS]. HIV_0217-030112.

18. Practical Convergent Laboratory-scale Synthesis of a CCR5 Receptor Antagonist. Crawford, J.B., G. Chen, B. Carpenter, T. Wilson, J. Ji, R.T. Skerlj, and G.J. Bridger, Organic Process Research & Development, 2012. 16(1): p. 109-116; ISI[000299238700015].
[WOS]. HIV_0217-030112.

19. Discovery of 5,6-Dihydro-indolo[1,2-a]quinoxaline Derivatives as New HIV-1 Inhibitors in Vitro. Fan, L.L., N. Huang, R.G. Yang, S.Z. He, L.M. Yang, H. Xu, and Y.T. Zheng, Letters in Drug Design & Discovery, 2012. 9(1): p. 44-47; ISI[000299566600008].
[WOS]. HIV_0217-030112.

20. Targeting Zinc Finger Domains with Small Molecules: Solution Structure and Binding Studies of the RanBP2-Type Zinc Finger of RBM5. Farina, B., R. Fattorusso, and M. Pellecchia, ChemBioChem, 2011. 12(18): p. 2837-2845; ISI[000297951300021].
[WOS]. HIV_0217-030112.

21. Amphipathic Properties of HIV-1 gp41 Fusion Inhibitors. Gochin, M. and G.Y. Zhou, Current Topics in Medicinal Chemistry, 2011. 11(24): p. 3022-3032; ISI[000299642200006].
[WOS]. HIV_0217-030112.

22. Interactions Between Buprenorphine and the Protease Inhibitors Darunavir-Ritonavir and Fosamprenavir-Ritonavir. Gruber, V.A., P.M. Rainey, D.E. Moody, G.D. Morse, Q. Ma, S. Prathikanti, P.A. Pade, A.A.H. Alvanzo, and E.F. McCance-Katz, Clinical Infectious Diseases, 2012. 54(3): p. 414-423; ISI[000299128000023].
[WOS]. HIV_0217-030112.

23. HIV Attachment Inhibitors with Measurable Aqueous Solubility, Significant Bioavailability, and High Potency. Johnson, B.L., D.J. Carini, A. Regueiro-Ren, S. Rahematpura, L.G. Hamann, J.F. Kadow, M. Zheng, D.D. Parker, B.D. Nowicka-Sans, S.R. Zhang, P.F. Lin, and N.A. Meanwell, Abstracts of Papers of the American Chemical Society, 2011. 242; ISI[000299378304759].
[WOS]. HIV_0217-030112.

24. In Vitro anti-HIV-1 Activity of the Aqueous Extract of Asterina pectinifera. Karadeniz, F., M.Z. Karagozlu, C.S. Kong, and S.K. Kim, Current HIV Research, 2011. 9(2): p. 95-102; ISI[000299645400004].
[WOS]. HIV_0217-030112.

25. A QSAR Study on Some Series of HIV-1 Integrase Inhibitors. Kaushik, S., S.P. Gupta, P.K. Sharma, and Z. Anwar, Medicinal Chemistry, 2011. 7(6): p. 553-560; ISI[000299577500004].
[WOS]. HIV_0217-030112.

26. A Curious Conformational Property of 2-Amino-4-thiazolyl-methoxyimino Polymers Exhibiting Activity against HIV-1 Reverse Transcriptase. Kill, K.A., A.C. Smith, T. Mizdalo, E.H. Al-Mahrouq, Nidhi, and D.B. Boyd, Structural Chemistry, 2012. 23(1): p. 137-145; ISI[000299769900017].
[WOS]. HIV_0217-030112.

27. Synthesis and HIV-1 Reverse Transcriptase Inhibition Activity of 1,4-Naphthoquinone Derivatives. Mahapatra, A., T.E. Tshikalange, J.J.M. Meyer, and N. Lall, Chemistry of Natural Compounds, 2012. 47(6): p. 883-887; ISI[000299516300005].
[WOS]. HIV_0217-030112.

28. Targeting Protein-Protein and Protein-Nucleic Acid Interactions for anti-HIV Therapy. Mori, M., F. Manetti, and M. Botta, Current Pharmaceutical Design, 2011. 17(33): p. 3713-3728; ISI[000299638000011].
[WOS]. HIV_0217-030112.

29. Defensins and Other Biocidal Proteins from Bean Seeds with Medicinal Activities. Ng, T.B., J.H. Wong, and E.F. Fang, Current Medicinal Chemistry, 2011. 18(36): p. 5644-5654; ISI[000299677400010].
[WOS]. HIV_0217-030112.

30. Design, Synthesis and SAR Study of Bridged Tricyclic pyrimidinone as HIV Integrase Inhibitors. Patel, M., B.N. Naidu, I. Dicker, H. Hingley, Z.Y. Lin, B. Terry, T. Protack, N.A. Meanwell, M. Krystal, and M.A. Walker, Abstracts of Papers of the American Chemical Society, 2011. 242; ISI[000299378304760].
[WOS]. HIV_0217-030112.

31. Preclinical Drug Metabolism and Pharmacokinetic Evaluation of Novel HMDCK Prodrugs as Potent anti-HIV NNRTIs. Qian, K.D., L. Xie, and K.H. Lee, Abstracts of Papers of the American Chemical Society, 2011. 242; ISI[000299378304761].
[WOS]. HIV_0217-030112.

32. Investigation of Structure-Activity Relationship Between Chemical Structure and CCR5 Anti HIV-1 Activity in a Class of 1-[N-(Methyl)-N- (phenylsulfonyl) amino]-2-(phenyl)-4-[4-(substituted)piperidin-1-yl]butane Derivatives: The Electronic-Topological Approach. Saracoglu, M., S.G. Kandemirli, M.A. Basaran, H. Sayiner, and F. Kandemirli, Current HIV Research, 2011. 9(5): p. 300-312; ISI[000299672100004].
[WOS]. HIV_0217-030112.

33. Towards the Synthesis of Novel Boronates as Potential HIV-1 Protease Inhibitors. Schreiber, J.D., A.L. Faulkner, L.L. Holmberg, J.J. Jennings, M.D. Frank, J.L. Nye, D.R. Clayton, and L. Fabry-Asztalos, Abstracts of Papers of the American Chemical Society, 2011. 242; ISI[000299378304625].

[WOS]. HIV_0217-030112.